Organigram Holdings Appoints New CEO to Drive Global Expansion
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
OrganiGram Holdings ( (TSE:OGI) ) has provided an announcement.
Organigram Holdings has appointed James Yamanaka, former Global Head of Strategy at British American Tobacco, as its new CEO, effective January 15, 2026. Yamanaka’s extensive experience in strategy and management is expected to bolster Organigram’s global aspirations, leveraging his track record of driving international growth and transforming businesses to enhance the company’s position in the cannabis industry.
The most recent analyst rating on (TSE:OGI) stock is a Hold with a C$2.50 price target. To see the full list of analyst forecasts on OrganiGram Holdings stock, see the TSE:OGI Stock Forecast page.
Spark’s Take on TSE:OGI Stock
According to Spark, TipRanks’ AI Analyst, TSE:OGI is a Neutral.
OrganiGram Holdings’ overall score reflects strong earnings performance and market position, offset by technical weakness and valuation concerns. The company’s financial performance shows potential, but cash flow management needs improvement. The positive sentiment from the earnings call suggests a promising long-term trajectory, despite current challenges.
To see Spark’s full report on TSE:OGI stock, click here.
More about OrganiGram Holdings
Organigram Holdings is a leading Canadian producer of cannabis, focusing on recreational cannabis products. The company aims to expand its international presence and is known for its high-quality products, trusted brands, and commitment to innovation.
Average Trading Volume: 182,825
Technical Sentiment Signal: Sell
Current Market Cap: C$295.5M
For a thorough assessment of OGI stock, go to TipRanks’ Stock Analysis page.
